CEO Reshma Kewalramani said the two lead assets Vertex will take over from Crinetics have the potential to deliver more than ...
Curium will spend up to $8B to buy Lantheus, a 70-year-old Massachusetts company that helped pioneer the field of radiopharmaceuticals. The future of Lantheus' Massachusetts workforce remains to be ...